Online Only Articles

Impact of corticosteroid pretreatment in pediatric patients with newly diagnosed B-lymphoblastic leukemia: a report from the Children’s Oncology Group

Department of Pediatrics and Perlmutter Cancer Center, NYU Langone Health, New York, NY
Department of Pediatrics, Benioff Children’s Hospital, and the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA
Department of Biostatistics, Colleges of Medicine, Public Health and Health Professions, University of Florida, Gainesville, FL
Department of Pediatrics University of Colorado School of Medicine and Children’s Hospital Colorado, Aurora, CO
HARP Pharma Consulting, Mystic, CT
Department of Pediatrics, Maine Children’s Cancer Program, Scarborough, ME
Department of Genetics, University of Alabama at Birmingham, Birmingham, AL
Department of Pathology, Wexner Medical Center, Ohio State University, Columbus, OH
Institute for Genomic Medicine, Nationwide Children’s Hospital and Departments of Pathology and Pediatrics, Ohio State University College of Medicine, Columbus, OH
Departments of Pathology and Medicine, University of Washington, Seattle, WA
Departments of Pathology and Oncology, Johns Hopkins Medical Institutions, Baltimore, MD
Departments of Pediatrics, UT Southwestern, Dallas, TX
Department of Pediatrics and the Center for Childhood Cancer Research, Children’s Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, PA, USA
Department of Pediatrics and Perlmutter Cancer Center, NYU Langone Health, New York, NY
Vol. 104 No. 11 (2019): November, 2019 https://doi.org/10.3324/haematol.2018.215616